Advertisement
Loading...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

6990.HK•HKSE
Healthcare
Biotechnology
HK$435.40
HK$-26.60(-5.76%)
Hong Kong Market is Open • 11:16
Advertisement

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) Stock Overview

Explore Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap101.5B
P/E RatioN/A
EPS (TTM)$-1.94
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

6990.HK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 28.18, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 101.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-5.76%
5-Day Change
-5.47%
1-Month Change
-5.55%
3-Month Change
12.39%
6-Month Change
-1.05%
Year-to-Date (YTD) Change
10.68%
1-Year Change
36.49%
3-Year Change
596.64%
5-Year Change
596.64%
All-Time (Max) Change
596.64%

Contact Information

https://kelun-biotech.com
400-688-7002
No. 666 Xinhua Avenue, Chengdu, NaN, 611100

Company Facts

20,450 Employees
IPO DateJul 11, 2023
CountryCN
Actively Trading

Frequently Asked Questions